Rosmarinic acid, major phenolic constituent of Greek sage herbal tea, modulates rat intestinal SGLT1 levels with effects on blood glucose

被引:40
作者
Azevedo, Marisa F. [1 ]
Lima, Cristovao F. [2 ]
Fernandes-Ferreira, Manuel [3 ]
Almeida, Maria Judite [1 ]
Wilson, Jonathan M. [4 ]
Pereira-Wilson, Cristina [1 ]
机构
[1] Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, P-4710057 Braga, Portugal
[2] Univ Minho, Dept Biol, CITAB Ctr Res & Technol Agroenvironm & Biol Sci, P-4710057 Braga, Portugal
[3] Univ Porto, CITAB, Dept Biol, Fac Sci, P-4100 Oporto, Portugal
[4] CIIMAR Ctr Interdisciplinar Invest Marinha & Ambi, Oporto, Portugal
关键词
Diabetes mellitus; Intestinal glucose absorption; Rosmarinic acid; Salvia fruticosa Miller; SGLT1; expression; GLUCAGON-LIKE PEPTIDE-1; BRUSH-BORDER MEMBRANE; SALVIA-OFFICINALIS; DIABETES-MELLITUS; TRANSPORT; COTRANSPORTER; EXPRESSION; PROLIFERATION; ABSORPTION; FRUTICOSA;
D O I
10.1002/mnfr.201000472
中图分类号
TS2 [食品工业];
学科分类号
100403 [营养与食品卫生学];
摘要
Scope: Previous results suggested that the effects of Salvia fruticosa tea (SFT) drinking on glucose regulation might be at the intestinal level. Here we aim to characterize the effects of SFT treatment and of its main phenolic constituent - rosmarinic acid (RA) - on the levels and localization of the intestinal Na+/glucose cotransporter-1 (SGLT1), the facilitative glucose transporter 2 and glucagon-like peptide-1 (GLP-1). Methods and results: Two models of SGLT1 induction in rats were used: through diabetes induction with streptozotocin (STZ) and through dietary carbohydrate manipulation. Drinking water was replaced with SFT or RA and blood parameters, liver glycogen and the levels of different proteins in enterocytes quantified. Two weeks of SFT treatment stabilized fasting blood glucose levels in STZ-diabetic animals. The increase in SGLT1 localized to the enterocyte brush-border membrane (BBM) induced by STZ treatment was significantly abrogated by treatment with SFT, without significant changes in total cellular transporter protein levels. No effects were observed on glucose transporter 2, Na+/K+-ATPase or glucagon-like peptide-1 levels by SFT. Additionally, SFT and RA for 4 days significantly inhibited the carbohydrate-induced adaptive increase of SGLT1 in BBM. Conclusion: SFT and RA modulate the trafficking of SGLT1 to the BBM and may contribute to the control of plasma glucose.
引用
收藏
页码:S15 / S25
页数:11
相关论文
共 50 条
[1]
Regulation of membrane trafficking and endocytosis by protein kinase C: emerging role of the pericentrion, a novel protein kinase C-dependent subset of recycling endosomes [J].
Alvi, F. ;
Idkowiak-Baldys, J. ;
Baldys, A. ;
Raymond, J. R. ;
Hannun, Y. A. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (03) :263-270
[2]
Azevedo M. F., 2008, THESIS U MINHO
[3]
Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid [J].
Baba, S ;
Osakabe, N ;
Natsume, M ;
Terao, J .
LIFE SCIENCES, 2004, 75 (02) :165-178
[4]
Diabetes mellitus and genetically programmed defects in β-cell function [J].
Bell, GI ;
Polonsky, KS .
NATURE, 2001, 414 (6865) :788-791
[5]
SMALL-INTESTINE HEXOSE-TRANSPORT IN EXPERIMENTAL DIABETES - INCREASED TRANSPORTER MESSENGER-RNA AND PROTEIN EXPRESSION IN ENTEROCYTES [J].
BURANT, CF ;
FLINK, S ;
DEPAOLI, AM ;
CHEN, J ;
LEE, WS ;
HEDIGER, MA ;
BUSE, JB ;
CHANG, EB .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :578-585
[7]
Insulin signaling and the regulation of glucose transport [J].
Chang, L ;
Chiang, SH ;
Saltiel, AR .
MOLECULAR MEDICINE, 2004, 10 (7-12) :65-71
[8]
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[9]
EFFECT OF DIETARY CARBOHYDRATE ON MONOSACCHARIDE UPTAKE BY MOUSE SMALL-INTESTINE INVITRO [J].
DIAMOND, JM ;
KARASOV, WH .
JOURNAL OF PHYSIOLOGY-LONDON, 1984, 349 (APR) :419-440
[10]
Mechanisms of action of glucagon-like peptide 1 in the pancreas [J].
Doyle, Maire E. ;
Egan, Josephine M. .
PHARMACOLOGY & THERAPEUTICS, 2007, 113 (03) :546-593